Coronavirus disease 2019 (COVID-19) caused a fatal pandemic worldwide. This review
aims to discuss laboratory, molecular, and serological methods and their advantages and …

A group of pneumonia patients was detected in Hubei Province, in China in December
2019. The etiology of the disease was unknown. Later, the researchers diagnosed the novel …

Clinical characteristics are essential for the correct diagnosis of diseases. The current review
aimed to summarize the global clinical characteristics of the COVID-19 patients …

Considering the increasing prevalence and burden of coronavirus disease 2019 (COVID-
19) disease and false-negative results in routine reverse transcription-polymerase chain …

COVID-19, a new respiratory infectious disease, was first reported at the end of 2019, in
Wuhan, China. Now, COVID-19 is still causing major loss of human life and economic …

The unending outburst of COVID-19 has reinforced the necessity of SARS-CoV-2
identification approaches for the prevention of infection transmission and the proper care of …

The novel coronavirus disease 2019 (COVID-19), caused by Severe Acute Respiratory
Syndrome Coronavirus-2 (SARS-CoV-2), was announced as a pandemic in March 2020 …

Introduction COVID-19 is a recent emerging pandemic whose prognosis is still unclear.
Diagnostic tools are the main players that not only indicate a possible infection but can …

Background: The role of laboratory parameters and the relationship of them with radiology
reports, CT scan and clinical outcomes in screening of COVID-19 patients not been …

While molecular testing with real-time polymerase chain reaction (RT-PCR) remains the
gold-standard test for COVID-19 diagnosis and screening, more rapid or affordable …